Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (291-300 of 541) with videos related to

Pageof 55
Sort By:
Journal of the American College of Cardiology|June 6, 2020
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art ReviewJoão Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.
American Heart Journal|July 11, 2019
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunctionTrygve S Hall, Thomas G von Lueder, Faiez Zannad, et al.
European Journal of Heart Failure|January 21, 2025
Circulating growth differentiation factor-15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20-year follow-up studyLuca Monzo, Constance Xhaard, João Pedro Ferreira, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 3, 2012
Galectin-3 mediates aldosterone-induced vascular fibrosisLaurent Calvier, Maria Miana, Pascal Reboul, et al.
International Journal of Cardiology|October 2, 2017
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiativeStefan Agewall, Lars H Tjessem, Patrick Rossignol, et al.
Clinical Kidney Journal|November 2, 2023
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)Pantelis Sarafidis, Fotini Iatridi, Charles Ferro, et al.
European Journal of Heart Failure|May 27, 2020
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Xavier Rossello, Stuart J Pocock, et al.
American Journal of Hypertension|May 6, 2020
Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME TrialJoão Pedro Ferreira, David Fitchett, Anne Pernille Ofstad, et al.
European Journal of Heart Failure|August 27, 2024
Association of ventricular-arterial coupling with biomarkers involved in heart failure pathophysiology - the STANISLAS cohortHannes Holm, Martin Magnusson, Amra Jujić, et al.
European Heart Journal. Cardiovascular Imaging|June 23, 2023
Layer myocardial strain is the most heritable echocardiographic traitOlivier Huttin, Constance Xhaard, Claire Dandine-Roulland, et al.
Pageof 55

Showing results (291-300 of 541) with videos related to

Sort By:
Pageof 55
Journal of the American College of Cardiology|June 6, 2020
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art ReviewJoão Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.
American Heart Journal|July 11, 2019
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunctionTrygve S Hall, Thomas G von Lueder, Faiez Zannad, et al.
European Journal of Heart Failure|January 21, 2025
Circulating growth differentiation factor-15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20-year follow-up studyLuca Monzo, Constance Xhaard, João Pedro Ferreira, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 3, 2012
Galectin-3 mediates aldosterone-induced vascular fibrosisLaurent Calvier, Maria Miana, Pascal Reboul, et al.
International Journal of Cardiology|October 2, 2017
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiativeStefan Agewall, Lars H Tjessem, Patrick Rossignol, et al.
Clinical Kidney Journal|November 2, 2023
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)Pantelis Sarafidis, Fotini Iatridi, Charles Ferro, et al.
European Journal of Heart Failure|May 27, 2020
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Xavier Rossello, Stuart J Pocock, et al.
American Journal of Hypertension|May 6, 2020
Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME TrialJoão Pedro Ferreira, David Fitchett, Anne Pernille Ofstad, et al.
European Journal of Heart Failure|August 27, 2024
Association of ventricular-arterial coupling with biomarkers involved in heart failure pathophysiology - the STANISLAS cohortHannes Holm, Martin Magnusson, Amra Jujić, et al.
European Heart Journal. Cardiovascular Imaging|June 23, 2023
Layer myocardial strain is the most heritable echocardiographic traitOlivier Huttin, Constance Xhaard, Claire Dandine-Roulland, et al.
Pageof 55